| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | WO2003033464A1 Process for preparation of 5-halogenoindoles |
| 04/24/2003 | WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032908A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/24/2003 | WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 04/24/2003 | WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078439 Reacting N-formylindoline with chlorosulfonic acid and thionyl chloride; and reacting the product with sodium bicarbonate and an aniline compound |
| 04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
| 04/24/2003 | US20030078431 Biheterocyclic compounds having high anticoagulant activity, used as inhibitors of factor Xa |
| 04/24/2003 | US20030078289 Indole carboxylic acids as thyroid receptor ligands |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 04/24/2003 | CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents |
| 04/24/2003 | CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | CA2461557A1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/23/2003 | EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/23/2003 | EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists |
| 04/23/2003 | EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303306A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 04/23/2003 | EP1303262A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 04/23/2003 | EP1086179B1 Energy transfer assay method and reagent |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0796111B1 In-vivo diagnostic process by near infrared radiation using cyanine dyes |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | CN1413426A Complexes of form L2MX as phosphorescent dopants for organic LEDS |
| 04/23/2003 | CN1413217A Olefin polymerization cocatalysts derived from group-15 compounds and process using them |
| 04/23/2003 | CN1413193A Nitrile derivatives as cathepsin K inhibitors |
| 04/23/2003 | CN1413192A Substituted indole mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels |
| 04/23/2003 | CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions |
| 04/23/2003 | CN1106383C Estrogenic agents |
| 04/22/2003 | US6552226 Tandem acyl-Claisen rearrangement in the preparation of chiral products |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552077 Kidney disorders |
| 04/22/2003 | US6552065 Antiproliferative agents |
| 04/22/2003 | US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation |
| 04/22/2003 | US6552044 Indane or dihydroindole derivatives |
| 04/22/2003 | US6552042 Anticoagulants |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
| 04/22/2003 | US6551495 Electrochemical assays |
| 04/22/2003 | CA2308780C Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 04/17/2003 | WO2003032072A2 Crosslinkable monomers for novel nonlinear optical polymers |
| 04/17/2003 | WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031409A1 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/17/2003 | WO2003030901A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | WO2003030842A1 Agent for colouring fibres containing keratin |
| 04/17/2003 | WO2003017927A3 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 04/17/2003 | WO2002092564A3 Synthesis of cyclopentadiene derivatives |
| 04/17/2003 | WO2002032960A3 Methods of selecting compounds for modulation of bladder function |
| 04/17/2003 | WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073871 Process for the oxidation of alcohols to aldehydes and ketones in the presence of nitroxyl compounds as catalysts |
| 04/17/2003 | US20030073866 Labeling nucleic acids with fluorescent complex of cyanine dye and carbodiimide compound |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
| 04/17/2003 | US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 04/17/2003 | US20030073848 Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols |
| 04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/17/2003 | US20030073846 Aminoalcohol derivatives |
| 04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
| 04/17/2003 | US20030073731 Alkylation therapy; anticancer agent |
| 04/17/2003 | US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders |
| 04/17/2003 | US20030073699 Compounds and methods to treat cardiac failure and other disorders |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | CA2461369A1 Arylsulphonyl-substituted tetrahydro-and-hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/16/2003 | EP1302460A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/16/2003 | EP1302459A1 Processes for preparation of fused pyrroles |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1302456A1 Process for oxidation of alcohols catalysed by nitroxyl compounds |
| 04/16/2003 | EP1301520A1 Ligands, complex compounds and their use for polymerising olefins |
| 04/16/2003 | EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 04/16/2003 | EP1301474A2 Tyrosine derivatives as phosphatase inhibitors |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1252803A4 Complexes of form l 2?mx as phosphorescent dopants for organic leds |
| 04/16/2003 | EP1054667B1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents |